Overview
Hemanext, is a novel technology to deliver red blood cells (RBCs) of higher efficacy for transfusion therapy, and at the same time, extend the shelf life of refrigerated RBCs.
“[HASP] represents a paradigm shift in the approach to storage of red cells, the most significant change since the introduction of additive solutions 25 years ago. As concern mounts about the clinical impact of storage time of red cell units, reduction in the storage lesion that accumulates has taken on increased importance. Anaerobic storage is a new tool that may not only lengthen but improve the storage of these life-saving cells.”
James AuBuchon, M.D.
President & CEO, Puget Sound Blood Center
Professor of Medicine & Laboratory Medicine, University of Washington